Viewing Study NCT06927960


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-27 @ 11:13 PM
Study NCT ID: NCT06927960
Status: COMPLETED
Last Update Posted: 2025-12-19
First Post: 2025-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration
Sponsor: AnHorn Medicines Co. Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AH-001-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators